Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
10/22/2009 | US20090263331 Multifunction nanoconjugates for imaging applications and targeted treatment |
10/22/2009 | US20090263330 Gas-filled microvesicles with polymer-modified lipids |
10/22/2009 | US20090263329 Cell labeling with perfluorocarbon nanoparticles for magnetic resonance imaging and spectroscopy |
10/22/2009 | US20090263328 Fluorescence observation apparatus and fluoroscopy method |
10/22/2009 | US20090263327 Minimally invasive physiological function monitoring agents |
10/22/2009 | US20090263326 Nano-scale contrast agents and methods of use |
10/22/2009 | US20090263325 Method and apparatus for the dissolution and filtration of a hyperpolarized agent with a neutral dissolution media |
10/22/2009 | US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing |
10/22/2009 | US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines |
10/22/2009 | US20090263317 Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease |
10/22/2009 | CA2758415A1 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
10/22/2009 | CA2721797A1 Magnetic microstructures for magnetic resonance imaging |
10/22/2009 | CA2721506A1 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
10/21/2009 | EP2110445A2 Molecular tagging system |
10/21/2009 | EP1169062B1 Heat stable coated colloidal iron oxides |
10/21/2009 | CN201329030Y New barium meal stirrer |
10/21/2009 | CN101563107A Radioactive diagnostic imaging agent |
10/21/2009 | CN100551440C Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
10/20/2009 | US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
10/20/2009 | US7605185 Treatment of arrhythmia by retinoids affecting signal transduction |
10/20/2009 | US7604810 Conserved Neisserial antigens |
10/20/2009 | CA2376497C Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
10/20/2009 | CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents |
10/20/2009 | CA2126761C Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
10/15/2009 | WO2009126832A2 Methods of permeabilizing and adding agents to cells |
10/15/2009 | WO2009126441A1 Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles |
10/15/2009 | WO2009125286A1 Polyvinyl alcohol microbubbles for releasing no |
10/15/2009 | WO2009053597A3 Novel method for preparing nanoparticles covered with an organic stabilising layer coupled to targeting ligands |
10/15/2009 | US20090260090 Apobec3 mediated dna editing |
10/15/2009 | US20090258012 Compositions and methods for treating inflammatory disorders |
10/15/2009 | US20090257956 Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation |
10/15/2009 | US20090257955 Sheep model of neuropathic pain behavior and uses thereof |
10/15/2009 | US20090257954 Development of a simple animal model for infection by viruses and other obligate intracellular parasites |
10/15/2009 | US20090257953 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography |
10/15/2009 | US20090257952 Engineered Integrin Binding Peptides |
10/15/2009 | US20090257950 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
10/15/2009 | DE10259793B4 Verfahren zur Bildgebung eines Stoffwechselvorgangs eines Lebewesens Method for imaging a metabolic process of an organism |
10/15/2009 | DE102008045937A1 Verbindung aus einem Metallion und einem Markierungsvorläufer und Verwendung der Verbindung Compound of a metal ion and a labeling precursor and use of the compound |
10/14/2009 | EP2108378A2 Non-covalent bioconjugates useful for diagnosis and therapy |
10/14/2009 | EP2108376A2 Prevention and treatment of amyloidogenic disease |
10/14/2009 | EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
10/14/2009 | EP1423019B1 Process for preparing concentrate thickener compositions |
10/14/2009 | EP1153129B1 Method of treating restenosis by antisense targeting of c-myc |
10/14/2009 | EP1144447B1 Tuberculosis diagnostic test |
10/14/2009 | EP1139793B1 Inhibitors of the bitter taste response |
10/14/2009 | CN101558169A Treatment of pigs with PCV2 antigen |
10/14/2009 | CN101558081A Fibrin binding peptide conjugates for diagnostic and therapeutic applications |
10/14/2009 | CN101557801A Hydrogels containing low molecular weight alginates and biostructures made therefrom |
10/14/2009 | CN101554574A Superparamagnetism nano particle jointly modified by aminosilane coupling agent and hyskon and preparation method thereof |
10/14/2009 | CN101554481A Difunctional imaging agent for SPECT and MRI and preparation method thereof |
10/14/2009 | CN101554340A Phototoxicity experiment detection device |
10/14/2009 | CN100548977C Prostaglandin-like compound and its uses for treatment of external secretion disorders |
10/14/2009 | CN100548465C Multiple responsive high molecular microcapsule and preparation method thereof |
10/14/2009 | CN100548387C Improved radiometal complex compositions |
10/14/2009 | CN100548386C Releasable polymeric conjugates based on biodegradable linkers |
10/14/2009 | CN100548293C Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
10/13/2009 | US7603167 Method and apparatus for 3-D imaging of internal light sources |
10/13/2009 | US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA |
10/13/2009 | US7601333 Use of a tetrapeptide AcSDKP (SEQ ID No. 1) analog resistant to the angiotensin I converting enzyme for measuring glomerular filtration rate in a human or an animal and kit containing same |
10/13/2009 | CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
10/13/2009 | CA2406629C Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
10/08/2009 | WO2009124273A2 Radiopharmaceutical imaging of neurodegenerative diseases |
10/08/2009 | WO2009123927A2 System and method for indirectly measuring calcium ion efflux |
10/08/2009 | WO2009122443A2 A tumor model system useful to study multistage cancer |
10/08/2009 | WO2009121993A1 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
10/08/2009 | WO2009080138A3 THE USE OF THE SPIN CROSSOVER COMPLEX [Mx+(L2)Hw]AN)z AS A MAGNETIC RESONANCE IMAGING CONTRAST AGENT |
10/08/2009 | WO2009053372A3 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
10/08/2009 | US20090255003 Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases |
10/08/2009 | US20090253896 Selective substrates for matrix metalloproteinases |
10/08/2009 | US20090252687 Asymmetric fluoro-substituted polymethine dyes |
10/08/2009 | US20090252686 Ex Vivo Hyperpolarization of Imaging Agents |
10/08/2009 | US20090252685 High penetration prodrug compositions of prostaglandins and related compounds |
10/08/2009 | US20090252684 Determination of tissue-specific profile of amino acid requirements form the relationship between the amounts of tRNAs for individual amino acids and the protein-bound amino acid profile of the tissue |
10/08/2009 | US20090252682 In-vivo optical imaging method including analysis of dynamic images |
10/08/2009 | US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR |
10/08/2009 | US20090252678 Cox-2-targeted imaging agents |
10/08/2009 | US20090252677 Probes for In Vivo Targeting of Active Cysteine Proteases |
10/08/2009 | US20090252676 N-alkoxyamide conjugates as imaging agents |
10/08/2009 | CA2720869A1 Radiopharmaceutical imaging of neurodegenerative diseases |
10/08/2009 | CA2720390A1 Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents |
10/07/2009 | EP2106808A1 Radioactive diagnostic imaging agent |
10/07/2009 | EP1613358B1 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications |
10/07/2009 | EP1283872B1 Catalytically active peptides |
10/07/2009 | EP1191099B1 Novel polypeptide and dna thereof |
10/07/2009 | EP0907735B2 Modulators of tissue regeneration |
10/07/2009 | CN101549161A Liver, spleen specific positive magnetic nuclear resonance contrast agent and method of preparing the same |
10/07/2009 | CN101548974A Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof |
10/07/2009 | CN100547284C Illuminating device |
10/07/2009 | CN100546658C Ligand of polyoxyethylene of containing target peptide toward to liver cancer and its synthesis method |
10/06/2009 | US7598341 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs |
10/06/2009 | US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
10/06/2009 | US7598046 Use of Apolipoprotein B, Apolipoprotein E, fragments for diagnostic, detection, prognostic and therapeutic applications In bovine spongiform encephalopathy (BSE) and Creutzfeld-Jacob Disease |
10/06/2009 | US7598041 HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same |
10/06/2009 | US7597891 Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases |
10/06/2009 | US7597887 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1) |
10/06/2009 | US7597877 Administering a gravity segregation dispersion by continuous infusion |
10/06/2009 | US7597875 Diaminedioxime radiometal complexes |
10/01/2009 | WO2009120836A1 Methods for identifying and targeting autonomic brain regions |
10/01/2009 | WO2009120244A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
10/01/2009 | WO2009100011A3 Targeted cellular selectivity of surface active molecules |